A. Koster and J. Raemaekers, Angiogenesis in malignant lymphoma, Current Opinion in Oncology, vol.17, issue.6, pp.611-617, 2005.
DOI : 10.1097/01.cco.0000181404.83084.b5

E. Passalidou, M. Stewart, and M. Trivella, Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma, British Journal of Cancer, vol.88, issue.4, pp.553-562, 2003.
DOI : 10.1038/sj.bjc.6600742

W. Zhao, S. Mourah, and N. Mounier, Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression, Laboratory Investigation, vol.103, issue.11, pp.1512-1521, 2004.
DOI : 10.1038/labinvest.3700145

A. Bujanda and D. , Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab, Annals of Oncology, vol.19, issue.2, pp.396-403, 2008.
DOI : 10.1093/annonc/mdm579

A. Alizadeh and R. Advani, Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies, Clin Adv Hematol Oncol, vol.6, pp.899-909, 2008.

I. Bruns, F. Fox, and P. Reinecke, Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab, Leukemia, vol.32, issue.11, pp.1993-1998, 2005.
DOI : 10.1182/blood-2004-01-0226

K. Dunleavy, W. Wilson, and E. Jaffe, Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications, Current Opinion in Hematology, vol.14, issue.4, pp.348-53, 2007.
DOI : 10.1097/MOH.0b013e328186ffbf

T. Kaneko, Z. Zhang, and M. Mantellini, Bcl-2 Orchestrates a Cross-talk between Endothelial and Tumor Cells that Promotes Tumor Growth, Cancer Research, vol.67, issue.20, pp.9685-93, 2007.
DOI : 10.1158/0008-5472.CAN-07-1497

P. Kumar, Y. Ning, and P. Polverini, Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion, Laboratory Investigation, vol.60, issue.7, pp.740-749, 2008.
DOI : 10.1016/j.bbrc.2005.12.201

C. Zhang, F. Song, J. Zhang, and Q. Song, Hypoxia-induced Bcl-2 expression in endothelial cells via p38 MAPK pathway, Biochemical and Biophysical Research Communications, vol.394, issue.4, pp.976-80, 2010.
DOI : 10.1016/j.bbrc.2010.03.102

P. Kumar, I. Coltas, and B. Kumar, Bcl-2 Protects Endothelial Cells against ??-Radiation via a Raf-MEK-ERK-Survivin Signaling Pathway That Is Independent of Cytochrome c Release, Cancer Research, vol.67, issue.3, pp.1193-202, 2007.
DOI : 10.1158/0008-5472.CAN-06-2265

C. Stein, S. Wu, and A. Voskresenskiy, G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, Alters In vitro Endothelial Cell Growth and Tubular Morphogenesis, Clinical Cancer Research, vol.15, issue.8, pp.2797-807, 2009.
DOI : 10.1158/1078-0432.CCR-08-2610

E. Fonsatti, H. Nicolay, M. Altomonte, A. Covre, and M. Maio, Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours, Cardiovascular Research, vol.86, issue.1, pp.12-21, 2010.
DOI : 10.1093/cvr/cvp332

V. Barresi, S. Cerasoli, E. Vitarelli, and G. Tuccari, Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas, Acta Neuropathologica, vol.34, issue.2, pp.147-56, 2007.
DOI : 10.1007/s00401-007-0251-4

S. Behrem, K. Zarkovic, N. Eskinja, and N. Jonjic, Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma, Croat Med J, vol.46, pp.417-439, 2005.

P. Kyzas, N. Agnantis, and D. Stefanou, Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma, Virchows Archiv, vol.9, issue.6, pp.768-75, 2006.
DOI : 10.1007/s00428-006-0195-4

Y. Sugita, Y. Takase, and D. Mori, Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival, Journal of Neuro-Oncology, vol.17, issue.3, pp.249-56, 2007.
DOI : 10.1007/s11060-006-9281-3

S. Swerdlow, E. Campo, N. Harris, and E. Jaffe, WHO classification of tumours of hematopoietic and lymphoid tissues, 2008.

P. Pautier, A. Devidas, and A. Delmer, Angioimmunoblastic-Like T-Cell Non Hodgkin's Lymphoma: Outcome After Chemotherapy in 33 Patients and Review of the Literature, Leukemia & Lymphoma, vol.88, issue.1, pp.545-52, 1999.
DOI : 10.1111/j.1365-2141.1991.tb08114.x

N. Weidner, J. Semple, W. Welch, and J. Folkman, Tumor Angiogenesis and Metastasis ??? Correlation in Invasive Breast Carcinoma, New England Journal of Medicine, vol.324, issue.1, pp.1-8, 1991.
DOI : 10.1056/NEJM199101033240101

P. Vermeulen, G. Gasparini, and S. Fox, Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours, European Journal of Cancer, vol.38, issue.12, pp.1564-79, 2002.
DOI : 10.1016/S0959-8049(02)00094-1

P. Vermeulen, G. Gasparini, and S. Fox, Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation, European Journal of Cancer, vol.32, issue.14, pp.2474-84, 1996.
DOI : 10.1016/S0959-8049(96)00379-6

K. Konstantinou, K. Yamamoto, and F. Ishibashi, Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma, British Journal of Haematology, vol.84, issue.5, pp.696-704, 2009.
DOI : 10.1111/j.1365-2141.2008.07534.x

C. Laurent, N. Fazilleau, and P. Brousset, A novel subset of T-helper cells: follicular T-helper cells and their markers, Haematologica, vol.95, issue.3, pp.356-364, 2010.
DOI : 10.3324/haematol.2009.019133

P. Went, C. Agostinelli, and A. Gallamini, Marker Expression in Peripheral T-Cell Lymphoma: A Proposed Clinical-Pathologic Prognostic Score, Journal of Clinical Oncology, vol.24, issue.16, pp.2472-2481, 2006.
DOI : 10.1200/JCO.2005.03.6327

R. Soltani-arabshahi, C. Leboeuf, and J. Rivet, Bcl-xL Gene Expression Correlated with Lower Apoptotic Cell Numbers and Shorter Progression-Free Survival in PCFCL, Journal of Investigative Dermatology, vol.129, issue.7, pp.1703-1712, 2009.
DOI : 10.1038/jid.2008.430

J. Hoefnagel, M. Vermeer, and P. Jansen, Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance, British Journal of Dermatology, vol.90, issue.6, pp.1183-91, 2003.
DOI : 10.1046/j.1365-2133.2002.47329.x

J. Jung, D. Kim, and E. Kwak, Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas, Annals of Hematology, vol.69, issue.9, pp.575-81, 2006.
DOI : 10.1007/s00277-006-0127-z

S. Kondo, Y. Tang, E. Scheef, N. Sheibani, and C. Sorenson, Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of bcl-2, AJP: Cell Physiology, vol.294, issue.6, pp.1521-1551, 2008.
DOI : 10.1152/ajpcell.90633.2007

E. Karl, Z. Zhang, and Z. Dong, Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells, Cell Death and Differentiation, vol.2, issue.9, pp.1657-66, 2007.
DOI : 10.1101/gad.252603

D. Enis, B. Shepherd, and Y. Wang, Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells, Proceedings of the National Academy of Sciences, vol.102, issue.2, pp.425-455, 2005.
DOI : 10.1073/pnas.0408357102

D. Enis, B. Dunmore, N. Johnson, J. Pober, and C. Print, Antiapoptotic Activities of Bcl-2 Correlate with Vascular Maturation and Transcriptional Modulation of Human Endothelial Cells, Endothelium, vol.26, issue.1-2, pp.59-71, 2008.
DOI : 10.1158/0008-5472.CAN-04-1437

J. Nor, J. Christensen, D. Mooney, and P. Polverini, Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression, The American Journal of Pathology, vol.154, issue.2, pp.375-84, 1999.
DOI : 10.1016/S0002-9440(10)65284-4

J. Nor, J. Christensen, and J. Liu, Up-Regulation of BCL2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth, Cancer Res, vol.61, pp.2183-2191, 2001.

S. Kumar, A. Ghellal, and C. Li, Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis, Cancer Res, vol.59, pp.856-61, 1999.

P. Wikstrom, I. Lissbrant, P. Stattin, L. Egevad, and A. Bergh, Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer, The Prostate, vol.97, issue.4, pp.268-75, 2002.
DOI : 10.1002/pros.10083

S. Duff, C. Li, J. Garland, and S. Kumar, CD105 is important for angiogenesis: evidence and potential applications, The FASEB Journal, vol.17, issue.9, pp.984-92, 2003.
DOI : 10.1096/fj.02-0634rev

P. Carmeliet, Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-938, 2005.
DOI : 10.1038/nature04478

G. Lenz, G. Wright, and S. Dave, Stromal Gene Signatures in Large-B-Cell Lymphomas, New England Journal of Medicine, vol.359, issue.22, pp.2313-2336, 2008.
DOI : 10.1056/NEJMoa0802885